Variables
|
Experimental group (n = 100)
|
Control group (n = 100)
|
Unadjusted p Valuea
|
Adjusted p value2
|
---|
Baseline
|
12 months
|
15 months
|
Baseline
|
12 months
|
15 months
|
---|
Blood hemoglobin
|
Blood hemoglobin (g/dl)
|
11.42 ± 0.35
|
11.13 ± 0.52**
|
11.24 ± 0.44* ‡ c
|
11.44 ± 0.37
|
10.92 ± 0.61**
|
10.81 ± 0.59** c
|
0.000**
|
0.02*
|
Anthropometric measures
|
Weight (kg)
|
7.57 ± 0.79
|
11.31 ± 0.95** b
|
12.04 ± 0.95** c
|
7.65 ± 0.72
|
10.69 ± 0.82** b
|
11.05 ± 0.80** c
|
0.000**
|
0.004*
|
Length (cm)
|
66.20 ± 1.87
|
81.50 ± 2.56** b
|
84.16 ± 1.99** c
|
66.11 ± 1.92
|
79.93 ± 1.94** b
|
82.12 ± 1.69** c
|
0.000**
|
0.01*
|
WAZ (z score)
|
−0.12 ± 0.92
|
0.51 ± 0.72** b
|
0.57 ± 0.65** c
|
0.01 ± 0.93
|
0.04 ± 0.75 b
|
−0.15 ± .0.70 c
|
0.000**
|
0.003*
|
LAZ (z score)
|
−0.25 ± 0.85
|
−0.01 ± 0.92 b
|
− 0.21 ± 1.33 c
|
−0.28 ± 0.97
|
− 0.57 ± 0.81* b
|
−0.78 ± 0.66** c
|
0.001*
|
0.04*
|
WLZ (z score)
|
0.11 ± 1.01
|
0.71 ± 0.80** b
|
1 ± 1.79* c
|
0.28 ± 1.25
|
0.42 ± 0.93 b
|
0.31 ± 0.88 c
|
0.001*
|
0.02*
|
- 1 values are mean ± SD
- a Undjusted p values are group x time of assessment interaction and were obtained by repeated measures ANOVA analysis. Experimental group, MNP and NMS; Control group, NMS only. WAZ Weight-for-age z score, LAZ Length-for-age z score, and WLZ Weight-for-length z score
- Difference between groups at same time point is significant (at the 0.05 level) when letters are same
- * Significantly different by paired t-test between baseline and selected time-point in the same intervention group at the 0.05 level
- ** Significantly different by paired t-test between baseline and selected time-point in the same intervention group at the 0.001 level
- ‡ Significantly different by paired t test between month 12 and 15 in the same intervention group at the 0.05 level
- 2 p value after adjusting for sex (Model 1) at 12 months, groups were compared using one-way ANCOVA